# Efinopegdutide vs semaglutide: liver fat in fatty liver

Source: https://pepvault.app/research/efinopegdutide-romero-gomez-2023

Last updated: 2026-11-18

Use: © PepVault. Read and cite with a link. Copying, bulk scraping, rewriting or republishing is not permitted (https://pepvault.app/terms#content).

[Research](https://pepvault.app/research) [Efinopegdutide](https://pepvault.app/research#efinopegdutide)

Randomized trial · people

# Efinopegdutide: 72.7% liver fat drop vs 42.3% on semaglutide

Checked against the paper November 2026 Randomized trial [Published by PepVault](https://pepvault.app/guides/how-we-research)

## The takeaway

In a head-to-head trial, efinopegdutide cut liver fat more than semaglutide at these doses, with similar weight loss and somewhat more gut side effects.

- **Kind:** Randomized trial
- **Studied in:** People
- **Number studied:** 145
- **Published:** 2023
- **Journal:** J Hepatol

## What they tested

The team tested whether efinopegdutide, which acts on both GLP-1 and glucagon receptors, lowers liver fat more than semaglutide in people with non-alcoholic fatty liver disease (NAFLD).

## How the study was done

A phase IIa randomized, open-label trial (everyone knew which drug they got) in 145 people with NAFLD and at least 10% liver fat, 33.1% of whom had type 2 diabetes. They were assigned to efinopegdutide 10 mg or semaglutide 1 mg, each given under the skin once a week for 24 weeks, with liver fat measured by MRI.

<!--promo-->

Model. Individual results vary.

PepVault for iPhone

## Taking efinopegdutide? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-flow&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## What they found

At week 24, liver fat fell by an average of 72.7% from its starting level in the efinopegdutide arm (90% CI 66.8-78.7) and by 42.3% in the semaglutide arm (90% CI 36.5-48.1), a significant gap (p <0.001). Body weight dropped 8.5% with efinopegdutide and 7.1% with semaglutide, a gap that was not statistically significant (p = 0.085). Side effects were slightly more common with efinopegdutide, mostly stomach and gut problems.

## What it doesn’t show

The trial was open-label, ran only 24 weeks and compared one dose of each drug. It measured liver fat on MRI, not liver inflammation or scarring, so it does not show an effect on NASH itself.

## The paper

Romero-Gómez et al. A phase IIa active-comparator-controlled study to evaluate the efficacy and safety of efinopegdutide in patients with non-alcoholic fatty liver disease. J Hepatol. 2023.

- [PubMed (PMID 37355043)](https://pubmed.ncbi.nlm.nih.gov/37355043/)
- [The paper (DOI 10.1016/j.jhep.2023.05.013)](https://doi.org/10.1016/j.jhep.2023.05.013)
- [ClinicalTrials.gov (NCT04944992)](https://clinicaltrials.gov/study/NCT04944992)

## The compound

- [Efinopegdutide: how it works, half-life, studied range and evidence](https://pepvault.app/peptides/efinopegdutide)
- [Efinopegdutide dose guide](https://pepvault.app/lab/dosage/efinopegdutide)

## With this study

### Efinopegdutide

- [Efinopegdutide: the full reference](https://pepvault.app/peptides/efinopegdutide)
- [Efinopegdutide dose guide](https://pepvault.app/lab/dosage/efinopegdutide)

### Mixing charts

- [10 mg vial](https://pepvault.app/tools/reconstitution-calculator/efinopegdutide-10mg)

### Studies

- [Efinopegdutide: MASH resolved in up to 63% vs 13% on placebo](https://pepvault.app/research/efinopegdutide-lawitz-2026)
- [Efinopegdutide: up to 7.2% more weight loss than placebo at 12 weeks](https://pepvault.app/research/efinopegdutide-di-prospero-2021)
- [All 3 studies](https://pepvault.app/research#efinopegdutide)

### Compared with

- [Semaglutide vs Efinopegdutide](https://pepvault.app/peptides/compare/semaglutide-vs-efinopegdutide)
- [Survodutide vs Efinopegdutide](https://pepvault.app/peptides/compare/survodutide-vs-efinopegdutide)
- [Pemvidutide vs Efinopegdutide](https://pepvault.app/peptides/compare/pemvidutide-vs-efinopegdutide)

### Tools

- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [How long will my vial last?](https://pepvault.app/tools/how-long-will-my-vial-last)
- [Is my mixed vial still good?](https://pepvault.app/tools/reconstituted-peptide-expiry)
- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)

### Terms on this page

- [GLP-1](https://pepvault.app/glossary/glp-1)
- [Glucagon](https://pepvault.app/glossary/glucagon)
- [Open-label](https://pepvault.app/glossary/open-label)
- [Statistically significant](https://pepvault.app/glossary/statistical-significance)

## More studies on Efinopegdutide

- [Efinopegdutide: MASH resolved in up to 63% vs 13% on placebo](https://pepvault.app/research/efinopegdutide-lawitz-2026) Randomized trial · people · 2026
- [Efinopegdutide: up to 7.2% more weight loss than placebo at 12 weeks](https://pepvault.app/research/efinopegdutide-di-prospero-2021) Randomized trial · people · 2021
- [Every study on Efinopegdutide](https://pepvault.app/research#efinopegdutide)

Researched and drafted with AI, then checked claim by claim against the primary sources linked below by a separate review pass. Published by PepVault. Last reviewed November 2026. Spot an error? [feedback@pepvault.app](mailto:feedback@pepvault.app). [How we research](https://pepvault.app/guides/how-we-research). This page reports one study; it is not medical advice.

<!--promo-->

[Track it in the app](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-next&mt=8)

<!--/promo-->

<!--promo-->

PepVault for iPhone

## Taking efinopegdutide? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-end&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

<!--promo-->

Model. Individual results vary.

PepVault for iPhone

## Taking efinopegdutide? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-rail&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## With this study

### Efinopegdutide

- [Efinopegdutide: the full reference](https://pepvault.app/peptides/efinopegdutide)
- [Efinopegdutide dose guide](https://pepvault.app/lab/dosage/efinopegdutide)

### Mixing charts

- [10 mg vial](https://pepvault.app/tools/reconstitution-calculator/efinopegdutide-10mg)

### Studies

- [Efinopegdutide: MASH resolved in up to 63% vs 13% on placebo](https://pepvault.app/research/efinopegdutide-lawitz-2026)
- [Efinopegdutide: up to 7.2% more weight loss than placebo at 12 weeks](https://pepvault.app/research/efinopegdutide-di-prospero-2021)
- [All 3 studies](https://pepvault.app/research#efinopegdutide)

### Compared with

- [Semaglutide vs Efinopegdutide](https://pepvault.app/peptides/compare/semaglutide-vs-efinopegdutide)
- [Survodutide vs Efinopegdutide](https://pepvault.app/peptides/compare/survodutide-vs-efinopegdutide)
- [Pemvidutide vs Efinopegdutide](https://pepvault.app/peptides/compare/pemvidutide-vs-efinopegdutide)

### Tools

- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [How long will my vial last?](https://pepvault.app/tools/how-long-will-my-vial-last)
- [Is my mixed vial still good?](https://pepvault.app/tools/reconstituted-peptide-expiry)
- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)

### Terms on this page

- [GLP-1](https://pepvault.app/glossary/glp-1)
- [Glucagon](https://pepvault.app/glossary/glucagon)
- [Open-label](https://pepvault.app/glossary/open-label)
- [Statistically significant](https://pepvault.app/glossary/statistical-significance)

<!--promo-->

PepVault for iPhone

## Taking efinopegdutide? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=study-card-sticky&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

## Research

- [All studies](https://pepvault.app/research)
- [Every study on Efinopegdutide](https://pepvault.app/research#efinopegdutide)

## The library

- [Efinopegdutide](https://pepvault.app/peptides/efinopegdutide)
- [Efinopegdutide dose guide](https://pepvault.app/lab/dosage/efinopegdutide)
- [The peptide reference library](https://pepvault.app/peptides)

## How we work

- [How we research](https://pepvault.app/guides/how-we-research)
- [How we check the library](https://pepvault.app/about#library)

PepVault is a research and tracking resource, not medical advice. Ranges are what studies used, never a dose for you. Brand names are trademarks of their owners; PepVault is independent of them.

PepVault is a private research and tracking tool, not medical advice. The information here is reference material from published literature and community use — always verify it and discuss any protocol with a qualified clinician before changing it.

© 2026 PepVault. Our text, data and tools may not be copied, scraped or republished without [permission](https://pepvault.app/terms#content).
